Vivos (RDGL) Shares Outstanding (2010 - 2025)
Vivos (RDGL) Shares Outstanding (2010 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | 385.10 Mn |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | 867.00 Mn |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | 951.57 Mn |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | 452.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 452.72 Mn |
| Sep 30, 2025 | 454.30 Mn |
| Jun 30, 2025 | 453.51 Mn |
| Mar 31, 2025 | 448.23 Mn |
| Dec 31, 2024 | 409.67 Mn |
| Sep 30, 2024 | 418.63 Mn |
| Jun 30, 2024 | 403.38 Mn |
| Mar 31, 2024 | 389.41 Mn |
| Dec 31, 2023 | 368.81 Mn |
| Sep 30, 2023 | 370.54 Mn |
| Jun 30, 2023 | 368.17 Mn |
| Mar 31, 2023 | 362.54 Mn |
| Dec 31, 2022 | 351.43 Mn |
| Sep 30, 2022 | 358.75 Mn |
| Jun 30, 2022 | 343.91 Mn |
| Mar 31, 2022 | 343.61 Mn |
| Dec 31, 2021 | 325.85 Mn |
| Sep 30, 2021 | 335.51 Mn |
| Jun 30, 2021 | 328.22 Mn |
| Mar 31, 2021 | 300.54 Mn |